Market Overview:
The global endocrine testing system market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of endocrine disorders, technological advancements in endocrine testing systems, and rising demand for point-of-care (POC) tests. Based on type, the global endocrine testing system market is segmented into tandem mass spectrometry, LC-MS/MS, immunoassay, monoclonal & polyclonal antibody technologies, sensor technology, clinical chemistry and others. Based on application, the market is segmented into hospitals laboratories commercial laboratories ambulatory care centres and other settings.
Product Definition:
Endocrine Testing System is a medical device that is used to measure the level of various hormones in the blood. The hormones that are most commonly measured include estrogen, progesterone, testosterone, and thyroid hormone levels. The importance of endocrine testing system lies in its ability to help diagnose and monitor conditions such as infertility, polycystic ovarian syndrome (PCOS), low testosterone levels (hypogonadism), and thyroid disorders.
Tandem Mass Spectrometry:
Tandem mass spectrometry is a technique that involves the separation of an analyte in question by its chemical properties and then measuring the quantity present in the sample. The tandem mass spectrum is generated by introducing a second substance, which reacts with the analyte to form a complex resulting in fragmentation of light into many different wavelengths. This allows for accurate quantification even for highly complicated molecules.
LC-MS/MS:
LC-MS/MS is a method used for the analysis of small molecules and macromolecules. It is an analytical tool that helps in identifying, quantifying, and analyzing the target compounds in biological samples. LC-MS/MS can be used to measure any type of hormones present in blood or other body fluids at very low concentrations.
Application Insights:
The other application segment includes endocrine testing systems used in home settings, workplace settings and institutional care centers. The hospital segment dominated the market for endocrine testing system owing to factors such as increasing prevalence of diseases such as CVDs, cancer and diabetes which mandates the use of these devices.
Moreover, an increase in number of hospitals due to rapid urbanization along with a rise in the number of diagnostic laboratories will boost industry growth over the forecast period. This is attributed to growing awareness about early detection among patients resulting in increased demand for these devices across hospitals worldwide.
On basis on application, this market has been classified into hospitals, commercial laboratories and others setting including home healthcare facilities and workplaces respectively.
Regional Analysis:
North America dominated the global endocrine testing system market in 2017. This can be attributed to the presence of sophisticated healthcare infrastructure, high adoption rate of advanced technologies, and increasing prevalence of target diseases such as diabetes and thyroid cancer & other disorders. Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to factors such as improving healthcare facilities due to rising investments by governments & private organizations, growing awareness about early diagnosis among patients, increase in disposable income levels resulting into higher demand for technologically advanced medical products & services along with rapidly developing economy that has attracted many international pharmaceutical companies for setting up their manufacturing units in this region. Moreover it provides huge opportunities for new segments catering to emerging markets like China and India which have a large base of geriatric population prone towards various chronic diseases requiring endocrine testing on regular basis.
Growth Factors:
- Increasing incidence of endocrine disorders
- Growing demand for personalized medicine
- Rising awareness about endocrine health
- Technological advancements in Endocrine Testing System market
- Growing number of clinical laboratories and hospitals
Scope Of The Report
Report Attributes
Report Details
Report Title
Endocrine Testing System Market Research Report
By Type
Tandem Mass Spectrometry, LC-MS/MS, Immunoassay, Monoclonal & Polyclonal antibody technologies, Sensor technology, Clinical chemistry, Others
By Application
Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting
By Companies
Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, DiaSorin, Fujirebio, Instrumentation Laboratory, Kyowa Medex, Ortho-Clinical Diagnostics, Roche, Siemens, Sysmex, Thermo Fisher, Tosoh, Danaher (AB Sciex), Agilent Technologies, Bio Rad Laboratories, LabCorp, Quest Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Endocrine Testing System Market Report Segments:
The global Endocrine Testing System market is segmented on the basis of:
Types
Tandem Mass Spectrometry, LC-MS/MS, Immunoassay, Monoclonal & Polyclonal antibody technologies, Sensor technology, Clinical chemistry, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- AdnaGen
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Fujirebio
- Instrumentation Laboratory
- Kyowa Medex
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Danaher (AB Sciex)
- Agilent Technologies
- Bio Rad Laboratories
- LabCorp
- Quest Diagnostics
Highlights of The Endocrine Testing System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tandem Mass Spectrometry
- LC-MS/MS
- Immunoassay
- Monoclonal & Polyclonal antibody technologies
- Sensor technology
- Clinical chemistry
- Others
- By Application:
- Hospitals
- Commercial Laboratories
- Ambulatory Care Centres
- Other Setting
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endocrine Testing System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Endocrine testing system is a medical device that helps diagnose endocrine disorders. It includes a number of different tests, including blood tests and urine samples.
Some of the major companies in the endocrine testing system market are Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, DiaSorin, Fujirebio, Instrumentation Laboratory, Kyowa Medex, Ortho-Clinical Diagnostics, Roche, Siemens, Sysmex, Thermo Fisher, Tosoh, Danaher (AB Sciex), Agilent Technologies, Bio Rad Laboratories, LabCorp, Quest Diagnostics.
The endocrine testing system market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endocrine Testing System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Endocrine Testing System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Endocrine Testing System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Endocrine Testing System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Endocrine Testing System Market Size & Forecast, 2020-2028
4.5.1 Endocrine Testing System Market Size and Y-o-Y Growth
4.5.2 Endocrine Testing System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tandem Mass Spectrometry
5.2.2 LC-MS/MS
5.2.3 Immunoassay
5.2.4 Monoclonal & Polyclonal antibody technologies
5.2.5 Sensor technology
5.2.6 Clinical chemistry
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Commercial Laboratories
6.2.3 Ambulatory Care Centres
6.2.4 Other Setting
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endocrine Testing System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endocrine Testing System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tandem Mass Spectrometry
9.6.2 LC-MS/MS
9.6.3 Immunoassay
9.6.4 Monoclonal & Polyclonal antibody technologies
9.6.5 Sensor technology
9.6.6 Clinical chemistry
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Commercial Laboratories
9.10.3 Ambulatory Care Centres
9.10.4 Other Setting
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tandem Mass Spectrometry
10.6.2 LC-MS/MS
10.6.3 Immunoassay
10.6.4 Monoclonal & Polyclonal antibody technologies
10.6.5 Sensor technology
10.6.6 Clinical chemistry
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Commercial Laboratories
10.10.3 Ambulatory Care Centres
10.10.4 Other Setting
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tandem Mass Spectrometry
11.6.2 LC-MS/MS
11.6.3 Immunoassay
11.6.4 Monoclonal & Polyclonal antibody technologies
11.6.5 Sensor technology
11.6.6 Clinical chemistry
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Commercial Laboratories
11.10.3 Ambulatory Care Centres
11.10.4 Other Setting
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tandem Mass Spectrometry
12.6.2 LC-MS/MS
12.6.3 Immunoassay
12.6.4 Monoclonal & Polyclonal antibody technologies
12.6.5 Sensor technology
12.6.6 Clinical chemistry
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Commercial Laboratories
12.10.3 Ambulatory Care Centres
12.10.4 Other Setting
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tandem Mass Spectrometry
13.6.2 LC-MS/MS
13.6.3 Immunoassay
13.6.4 Monoclonal & Polyclonal antibody technologies
13.6.5 Sensor technology
13.6.6 Clinical chemistry
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Commercial Laboratories
13.10.3 Ambulatory Care Centres
13.10.4 Other Setting
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endocrine Testing System Market: Competitive Dashboard
14.2 Global Endocrine Testing System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 AdnaGen
14.3.3 Beckman Coulter/Danaher
14.3.4 Biomedical Diagnostics
14.3.5 BioMerieux
14.3.6 Bio-Rad
14.3.7 DiaSorin
14.3.8 Fujirebio
14.3.9 Instrumentation Laboratory
14.3.10 Kyowa Medex
14.3.11 Ortho-Clinical Diagnostics
14.3.12 Roche
14.3.13 Siemens
14.3.14 Sysmex
14.3.15 Thermo Fisher
14.3.16 Tosoh
14.3.17 Danaher (AB Sciex)
14.3.18 Agilent Technologies
14.3.19 Bio Rad Laboratories
14.3.20 LabCorp
14.3.21 Quest Diagnostics
